Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C
INSERM U.319, Université Paris 7, France.
Lab Invest. 1994 May;70(5):656-66.
In the rat, in utero exposure to gentamicin during early renal differentiation leads to a permanent nephron deficit. The aim of the present study was to analyze, in vitro, the potential direct effect of gentamicin on early nephrogenesis.
We used paired rat metanephric organ cultures from 14 (F14) or 15-day-old (F15) fetuses. We measured gentamicin accumulation into explanted metanephroi and then assessed in vitro growth in the absence or presence of the drug. Glomerular labeling and counting were performed on the whole explant to analyze the effect of antibiotics on early nephrogenesis.
Growth of F14 metanephric explants in the presence of 50 micrograms of gentamicin/ml was significantly reduced from 4 days onwards as compared to controls, whereas F15 explants grown with gentamicin displayed a normal in vitro development. After 6 days of culture, F14 and F15 explants had the same accumulation of gentamicin (1 microgram/mg protein) but the gentamicin content was 4 times larger in F15 explants. At both ages, gentamicin-exposed metanephric explants exhibited a significant reduction in their number of nephrons. However, the effects of 50 micrograms of gentamicin/ml on nephrogenesis were significantly more drastic on F14 than F15 explants (35% versus 18%). When grown with 0.5 microgram of gentamicin/ml, F14 explants still exhibited a 16% defect in nephrogenesis as compared with controls, and about the same reduction was observed for cultures in the presence of 100 micrograms/ml of streptomycin and 100 IU/ml of penicillin. Incubation of F14 explants with streptomycin alone for 6 days had no effect on nephrogenesis.
These results indicate that gentamicin induces a significant reduction in the number of nephrons in metanephric explants and that this effect is more important on less differentiated metanephroi. Metanephric organ culture combined with glomerular labeling represents a useful model to test the effect of various growth factors and other drugs on early nephrogenesis.
在大鼠中,早期肾脏分化期间子宫内暴露于庆大霉素会导致永久性肾单位缺失。本研究的目的是在体外分析庆大霉素对早期肾发生的潜在直接影响。
我们使用了来自14日龄(F14)或15日龄(F15)胎儿的配对大鼠后肾器官培养物。我们测量了庆大霉素在植入的后肾中的积累,然后在有无药物的情况下评估体外生长情况。对整个植入物进行肾小球标记和计数,以分析抗生素对早期肾发生的影响。
与对照组相比,在含有50微克/毫升庆大霉素的情况下,F14后肾植入物从第4天起生长明显减少,而在庆大霉素存在下生长的F15植入物显示出正常的体外发育。培养6天后,F14和F15植入物的庆大霉素积累量相同(1微克/毫克蛋白质),但F15植入物中的庆大霉素含量是F14的4倍。在两个年龄段,暴露于庆大霉素的后肾植入物的肾单位数量均显著减少。然而,50微克/毫升庆大霉素对肾发生的影响在F14植入物上比在F15植入物上更为显著(35%对18%)。当在含有0.5微克/毫升庆大霉素的情况下生长时,与对照组相比,F14植入物的肾发生仍有16%的缺陷,并且在含有100微克/毫升链霉素和100国际单位/毫升青霉素的培养物中也观察到了大致相同的减少。单独用链霉素孵育F14植入物6天对肾发生没有影响。
这些结果表明,庆大霉素可导致后肾植入物中的肾单位数量显著减少,并且这种影响在分化程度较低的后肾中更为重要。后肾器官培养结合肾小球标记是测试各种生长因子和其他药物对早期肾发生影响的有用模型。